Crescita Therapeutics Inc banner

Crescita Therapeutics Inc
OTC:CRRTF

Watchlist Manager
Crescita Therapeutics Inc Logo
Crescita Therapeutics Inc
OTC:CRRTF
Watchlist
Price: 0.552 USD Market Closed
Market Cap: $10.8m

Intrinsic Value

CRRTF doesn't have a meaningful market cap.

The intrinsic value for Crescita Therapeutics Inc (CRRTF) under the Base Case is 0.578 USD. Compared with the current market price of 0.552 USD, the stock appears Undervalued by 4% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

CRRTF Intrinsic Value
0.578 USD
Undervaluation 4%
Intrinsic Value
Price $0.552
Bear Case
Base Case
Bull Case
Monitor CRRTF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.46
Get notified when the price drops into your buy zone
Intrinsic Value $0.58
Current Price $0.55
Margin of Safety 20% $0.46
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about CRRTF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CRRTF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Crescita Therapeutics Inc.

Explain Valuation
Alternatives to CRRTF

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one CRRTF stock?

The intrinsic value for Crescita Therapeutics Inc (CRRTF) under the Base Case is 0.578 USD.

Is CRRTF stock undervalued or overvalued?

Compared with the current market price of 0.552 USD, the stock appears Undervalued by 4% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett